Skip to Content

UK Edition. Click here for US version.



PDF options:  View Fullscreen   Download PDF

PDF Transcript

See section 4.

If you take pioglitazone with other medicines for
diabetes, it is more likely that your blood sugar
could fall below the normal level (hypoglycaemia).

patients, particularly women

Children and adolescents
Use in children and adolescents under 18
years is not recommended.


You can usually continue to take other medicines
whilst you are being treated with pioglitazone.

If you are pregnant or breast-feeding, think
you may be pregnant or are planning to have a
baby, ask your doctor or pharmacist for advice
before taking this medicine.


If you take anti-inflammatory medicines
which can cause fluid retention and

If you are following a diabetic diet, you should
continue with it while you are taking pioglitazone.

Reporting of side effects
If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. You can
also report side effects directly via the Yellow
Card Scheme at:
By reporting side effects you can help provide
more information on the safety of this medicine.

(may affect up to 1 in 10 people)

uncommonly (may affect up to 1 in 100 people)

(may affect up to 1 in 10 people)

the back of the eye (frequency cannot be
estimated from the available data) has also
been reported in patients taking pioglitazone.
If you experience this symptom for the first
time, talk to your doctor as soon as possible.
Also, if you already have blurred vision and
the symptoms get worse, talk to your doctor
as soon as possible.
- Allergic reactions have been reported
(frequency cannot be estimated from the
available data) in patients taking pioglitazone.
If you have a serious allergic reaction, including
hives and swelling of the face, lips, tongue,
or throat that may cause difficulty in breathing
or swallowing, stop taking this medicine
and talk to your doctor as soon as possible.
The following side effects have been experienced
by some patients taking pioglitazone:


frequency not known



allergic reactions

September 2014.

+ Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.